News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
212,115 Results
Type
Article (12139)
Company Profile (18)
Press Release (199957)
Multimedia
Podcasts (22)
Webinars (7)
Section
Business (69466)
Career Advice (675)
Deals (12660)
Drug Delivery (28)
Drug Development (25887)
Employer Resources (52)
FDA (4880)
Job Trends (4722)
News (102323)
Policy (9196)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (1105)
Academic (1)
Accelerated approval (16)
ADA (11)
Allergies (76)
Alliances (19262)
ALS (94)
Alzheimer's disease (676)
Antibody-drug conjugate (ADC) (258)
Approvals (5227)
Artificial intelligence (318)
ASCO (108)
Autoimmune disease (147)
Automation (23)
Bankruptcy (51)
Best Places to Work (3977)
BIO (24)
BIOSECURE Act (1)
Biosimilars (156)
Biotechnology (16)
Bladder cancer (65)
Brain cancer (28)
Breast cancer (249)
Cancer (2289)
Cardiovascular disease (167)
Career advice (584)
Career pathing (17)
CAR-T (105)
CDC (11)
Cell therapy (324)
Cervical cancer (19)
Clinical research (22488)
Collaboration (1091)
Commercialization (1)
Company closure (3)
Compensation (61)
Complete response letters (14)
COVID-19 (2014)
CRISPR (59)
C-suite (488)
Cystic fibrosis (58)
Data (3058)
Decentralized trials (1)
Denatured (19)
Depression (57)
Dermatology (57)
Diabetes (161)
Diagnostics (2534)
Digital health (27)
Diversity (7)
Diversity, equity & inclusion (15)
Drug discovery (189)
Drug pricing (40)
Drug shortages (1)
Duchenne muscular dystrophy (79)
Earnings (17612)
Editorial (9)
Employer branding (6)
Employer resources (55)
Events (26687)
Executive appointments (432)
FDA (6262)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (16)
Funding (926)
Gene editing (108)
Generative AI (27)
Gene therapy (197)
GLP-1 (320)
Government (1375)
Grass and pollen (4)
Guidances (125)
Healthcare (5721)
Hematology (68)
HIV (35)
Huntington's disease (16)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (39)
Immunology and inflammation (83)
Immuno-oncology (49)
Indications (81)
Infectious disease (2135)
Inflammatory bowel disease (82)
Inflation Reduction Act (7)
Influenza (68)
Intellectual property (111)
Interviews (127)
IPO (6173)
IRA (16)
Job creations (842)
Job search strategy (458)
JPM (13)
Kidney cancer (5)
Labor market (24)
Layoffs (98)
Leadership (21)
Legal (2072)
Liver cancer (39)
Longevity (16)
Lung cancer (299)
Lymphoma (196)
Machine learning (20)
Management (21)
Manufacturing (352)
Marketing (4)
MASH (56)
Medical device (3886)
Medtech (3940)
Mergers & acquisitions (7116)
Metabolic disorders (418)
mRNA (107)
Multiple sclerosis (60)
NASH (1)
Neurodegenerative disease (161)
Neuropsychiatric disorders (29)
Neuroscience (1248)
NextGen: Class of 2026 (1886)
Non-profit (1291)
Now hiring (2)
Obesity (193)
Opinion (68)
Ovarian cancer (76)
Pain (72)
Pancreatic cancer (111)
Parkinson's disease (165)
Partnered (12)
Patents (184)
Patient recruitment (276)
Peanut (16)
People (20647)
Pharmaceutical (6)
Pharmacy benefit managers (10)
Phase 1 (6677)
Phase 2 (9550)
Phase 3 (8465)
Pipeline (3549)
Policy (60)
Postmarket research (754)
Preclinical (2802)
Press Release (20)
Prostate cancer (97)
Psychedelics (12)
Radiopharmaceuticals (91)
Rare diseases (315)
Real estate (1516)
Recruiting (22)
Regulatory (7596)
Reports (9)
Research institute (990)
Resumes & cover letters (84)
Rett syndrome (7)
RNA editing (9)
RSV (27)
Schizophrenia (54)
Series A (209)
Series B (167)
Service/supplier (2)
Sickle cell disease (19)
Special edition (4)
Spinal muscular atrophy (29)
Sponsored (12)
Startups (1772)
Stomach cancer (4)
Supply chain (35)
Tariffs (4)
The Weekly (3)
Vaccines (492)
Venture capital (42)
Weight loss (73)
Women's health (56)
Worklife (13)
Date
Today (39)
Last 7 days (149)
Last 30 days (663)
Last 365 days (9455)
2026 (5489)
2025 (9124)
2024 (10862)
2023 (12721)
2022 (18905)
2021 (20782)
2020 (20244)
2019 (14016)
2018 (10579)
2017 (9934)
2016 (9125)
2015 (11108)
2014 (8025)
2013 (6383)
2012 (6453)
2011 (6732)
2010 (5800)
Location
Africa (244)
Alabama (38)
Alaska (4)
Arizona (67)
Arkansas (5)
Asia (28457)
Australia (3527)
California (4073)
Canada (1233)
China (826)
Colorado (269)
Connecticut (207)
Delaware (151)
Europe (33554)
Florida (530)
Georgia (69)
Hawaii (2)
Idaho (21)
Illinois (278)
India (65)
Indiana (130)
Iowa (8)
Japan (439)
Kansas (27)
Kentucky (9)
Louisiana (14)
Maine (13)
Maryland (431)
Massachusetts (3070)
Michigan (48)
Minnesota (177)
Mississippi (5)
Missouri (30)
Montana (7)
Nebraska (6)
Nevada (39)
New Hampshire (25)
New Jersey (1356)
New Mexico (8)
New York (1251)
North Carolina (408)
North Dakota (5)
Northern California (2195)
Ohio (114)
Oklahoma (10)
Oregon (17)
Pennsylvania (711)
Puerto Rico (5)
Rhode Island (13)
South America (276)
South Carolina (10)
South Dakota (1)
Southern California (1489)
Tennessee (46)
Texas (449)
United States (14236)
Utah (140)
Vermont (2)
Virginia (137)
Washington D.C. (30)
Washington State (393)
West Virginia (2)
Wisconsin (44)
212,115 Results for "samsung medison co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
With PolyPeptide manufacturing peptides such as GLP-1 medicines, Samsung Biologics has identified the deal as a way to tap into fast-growing demand for obesity drug production services.
July 21, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Samsung Biologics Reports Second Quarter 2026 Financial Results
July 23, 2026
·
5 min read
Press Releases
Samsung Bioepis Releases Third Quarter 2026 Biosimilar Market Report
July 23, 2026
·
2 min read
Press Releases
Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results
July 24, 2026
·
5 min read
Press Releases
Samsung Biologics Releases 2026 ESG Report, Highlighting Progress in Sustainable Operations and Responsible Growth
June 30, 2026
·
4 min read
Press Releases
Samsung Epis Holdings Reports First Quarter 2026 Financial Results
April 23, 2026
·
4 min read
Press Releases
Teva and Samsung Bioepis Enter Commercialization Agreement for OPUVIZ®, a Biosimilar Referencing Eylea® (aflibercept), in Canada
July 9, 2026
·
5 min read
Press Releases
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
July 1, 2026
·
8 min read
Press Releases
Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan
May 20, 2026
·
2 min read
Press Releases
GRAIL Completes $110 Million Equity Financing With Samsung Entities
June 25, 2026
·
9 min read
1 of 21,212
Next
